...
首页> 外文期刊>Contraception >Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium
【24h】

Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium

机译:含左炔诺孕酮或氯麦酮的联合口服避孕药对内皮的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Although the use of combined oral contraceptives (COCs) is associated with an increased risk of arterial and venous thromboembolic events, less is known about the impact of COCs on endothelial function. The present study evaluated the effects on the endothelium of healthy women of combinations of 30 mcg ethinylestradiol (EE)/2 mg chlormadinone acetate (CMA) and 30 mcg EE/150 mcg levonorgestrel (LNG). Study Design: Sixty-four healthy women were evaluated, 21 using a nonhormonal contraceptive method (control) and 43 using COCs, randomized to EE 30 mcg /CMA 2 mg or to EE 30 mcg/LNG 150 mcg. Anthropometric parameters, systolic arterial pressure (SAP), diastolic arterial pressure (DAP), ultrasound markers of endothelial function, flow-mediated dilation (FMD) of the brachial artery, intima-media thickness (IMT) and common carotid artery stiffness were measured at randomization and 6 months later. Results: Relative to baseline, EE/CMA users showed a significant reduction in mean DAP at 6 months (p=.02), and EE/LNG users showed a significant increase in mean IMT (p=.02) and a significant reduction in mean FMD (p=.01) at 6 months. DAP at 6 months was significantly lower in COC users than in controls (p=.01). Intergroup evaluations showed that, at 6 months, mean SAP (p=.02) was significantly lower in EE/LNG users than in controls (p=.02) and that mean DAP was significantly lower in EE/CMA (p<.01) and EE/LNG (p=.01) users than in controls. EE/LNG users experienced a mean FMD reduction almost threefold greater than that of EE/CMA users. Compared to controls, EE/LNG users experienced a 7.5-fold greater reduction in mean FMD. Conclusions: COC containing LNG is associated with more pronounced changes in the FMD and IMT of healthy women than a COC containing CMA and nonhormonal contraception. Further studies are needed to determine whether these differences may lead to higher risk of arterial thromboembolic events.
机译:背景:尽管联合使用口服避孕药(COCs)会增加动脉和静脉血栓栓塞事件的风险,但对COCs对内皮功能的影响知之甚少。本研究评估了30 mcg乙炔雌二醇(EE)/ 2 mg醋酸氯麦酮(CMA)和30 mcg EE / 150 mcg左炔诺孕酮(LNG)的组合对健康女性内皮细胞的作用。研究设计:评估了64名健康女性,其中21名使用非激素避孕方法(对照),43名使用COC,随机分为EE 30 mcg / CMA 2 mg或EE 30 mcg / LNG 150 mcg。人体测量参数,收缩压(SAP),舒张压(DAP),内皮功能超声标记,肱动脉血流介导的扩张(FMD),内膜中层厚度(IMT)和颈总动脉僵硬度随机和6个月后。结果:相对于基线,EE / CMA用户显示6个月时平均DAP显着降低(p = .02),EE / LNG用户显示平均IMT显着提高(p = .02), 6个月时的平均FMD(p = .01)。 COC使用者在6个月时的DAP显着低于对照组(p = .01)。小组间评估显示,在6个月时,EE / LNG用户的平均SAP(p = .02)显着低于对照组(p = .02),并且EE / CMA的DAP均显着降低(p <.01 )和EE / LNG(p = .01)用户。 EE / LNG用户的平均FMD降低几乎是EE / CMA用户的三倍。与对照组相比,EE / LNG用户的平均FMD降低了7.5倍。结论:与含有CMA和非激素避孕药的COC相比,含有LNG的COC与健康女性的FMD和IMT的变化更为明显。需要进一步研究以确定这些差异是否可能导致更高的动脉血栓栓塞事件风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号